Enhancers are regulatory regions of the DNA, giving rise to “long non-coding RNAs” (lncRNAs), which are known as crucial regulators of gene expression. Scientists from the Max Planck Institute for Molecular Genetics in Berlin now have shown that a…

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins, today announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held…

Take this unique opportunity to acquire Bayer as a customer

A new drug to help young patients with genetic obesity

Unisensor produces the lateral flow biosticks for its unique Extenso platform with SCIENION’s unrivalled sciFLEXARRAYER ultra-low volume dispensers

Year marked by advance of clinical strategy

First licensing agreement for lead compound lefitolimod concluded | Significant progress in studies | Company funding secured until the end of 2018 through successful capital measures

Charité clinician Regine Heilbronn and her research team convince the Federal Ministry of Education and Research (BMBF) at the GO-Bio Competition, daring to take the leap from the laboratory to medical application. The scientists were chosen for…

Berlin, Germany, April 18th, 2018